IRIS
Grandi, Guido
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 7.936
AS - Asia 2.766
EU - Europa 1.668
SA - Sud America 702
Continente sconosciuto - Info sul continente non disponibili 297
AF - Africa 75
OC - Oceania 11
Totale 13.455
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 7.741
SG - Singapore 965
VN - Vietnam 693
CN - Cina 575
BR - Brasile 552
IT - Italia 373
RU - Federazione Russa 304
SE - Svezia 165
FI - Finlandia 159
GB - Regno Unito 133
FR - Francia 112
CA - Canada 95
DE - Germania 93
LV - Lettonia 91
HK - Hong Kong 88
KR - Corea 74
TR - Turchia 63
ID - Indonesia 61
BG - Bulgaria 60
IN - India 58
AR - Argentina 56
BD - Bangladesh 52
EC - Ecuador 32
MX - Messico 32
UA - Ucraina 30
IQ - Iraq 24
NL - Olanda 24
ZA - Sudafrica 24
CO - Colombia 23
PL - Polonia 23
ES - Italia 21
IL - Israele 19
AT - Austria 18
CL - Cile 14
GT - Guatemala 14
JP - Giappone 12
CZ - Repubblica Ceca 11
PK - Pakistan 11
AU - Australia 10
VE - Venezuela 10
JM - Giamaica 9
DZ - Algeria 8
MA - Marocco 8
SK - Slovacchia (Repubblica Slovacca) 8
TN - Tunisia 8
AE - Emirati Arabi Uniti 7
CH - Svizzera 7
GP - Guadalupe 7
PE - Perù 7
PH - Filippine 7
SC - Seychelles 7
TH - Thailandia 7
UZ - Uzbekistan 7
BE - Belgio 6
CW - ???statistics.table.value.countryCode.CW??? 6
PR - Porto Rico 6
PY - Paraguay 6
SA - Arabia Saudita 6
CR - Costa Rica 5
EG - Egitto 5
HN - Honduras 5
IE - Irlanda 5
KE - Kenya 5
KZ - Kazakistan 5
NI - Nicaragua 5
PT - Portogallo 5
RO - Romania 5
TT - Trinidad e Tobago 5
AM - Armenia 4
JO - Giordania 4
LT - Lituania 4
SV - El Salvador 4
TW - Taiwan 4
ET - Etiopia 3
NP - Nepal 3
BB - Barbados 2
BW - Botswana 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
GR - Grecia 2
IR - Iran 2
KG - Kirghizistan 2
LB - Libano 2
PA - Panama 2
RS - Serbia 2
SN - Senegal 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AF - Afghanistan, Repubblica islamica di 1
AL - Albania 1
AZ - Azerbaigian 1
BH - Bahrain 1
BO - Bolivia 1
BY - Bielorussia 1
CU - Cuba 1
CY - Cipro 1
EU - Europa 1
GA - Gabon 1
GE - Georgia 1
HR - Croazia 1
KH - Cambogia 1
Totale 13.154
Salva come PNG Salva come JPEG
Città #
Fairfield 853
Ashburn 775
Singapore 596
Chandler 494
Woodbridge 391
Seattle 374
Houston 323
San Jose 321
Wilmington 315
Cambridge 310
Santa Clara 240
Columbus 226
Council Bluffs 225
Ho Chi Minh City 191
Dallas 186
Ann Arbor 178
Princeton 164
Jacksonville 153
Beijing 151
San Mateo 151
Hanoi 134
Moscow 125
Riga 91
The Dalles 91
Dong Ket 90
Helsinki 85
Hong Kong 84
Los Angeles 84
Lauterbourg 80
New York 77
Seoul 73
Hangzhou 69
Phoenix 69
San Diego 59
Sofia 57
Trento 56
Dearborn 53
Izmir 51
São Paulo 47
Da Nang 40
Jakarta 39
Chicago 38
Buffalo 34
San Paolo di Civitate 33
Orem 30
London 26
Como 24
Haiphong 24
Munich 24
Boardman 22
Montreal 21
Rio de Janeiro 20
Rome 20
Brooklyn 19
Warsaw 18
Norwalk 17
Chennai 16
Altamura 15
Atlanta 15
Johannesburg 15
Milan 15
Naples 15
Guangzhou 14
Hefei 14
Toronto 14
Biên Hòa 13
Washington 13
Guatemala City 12
Hải Dương 12
North Bergen 12
Nuremberg 12
Salt Lake City 11
Thái Bình 11
Baghdad 10
Can Tho 10
Des Moines 10
Miami 10
Quito 10
Redondo Beach 10
Tokyo 10
Brasília 9
Frankfurt am Main 9
Nanjing 9
Ninh Bình 9
Riverside 9
Shanghai 9
Stockholm 9
The Bronx 9
Belo Horizonte 8
Boston 8
Bratislava 8
Brno 8
Bắc Ninh 8
Denver 8
Fortaleza 8
Fremont 8
Kingston 8
Manchester 8
Mexico City 8
Paris 8
Totale 9.008
Salva come PNG Salva come JPEG
Nome #
Prochymosin expression in Bacillus subtilis 269
Vaccination with a FAT1-derived B cell epitope combined with tumor-specific B and T cell epitopes elicits additive protection in cancer mouse models 249
Protectome analysis: A new selective bioinformatics tool for bacterial vaccine candidate discovery 248
Some Gram-negative lipoproteins keep their surface topology when transplanted from one species to another and deliver foreign polypeptides to the bacterial surface 247
Structure of the type IX Group B Streptococcus capsular polysaccharide and its evolutionary relationship with types V and VII 246
Vaccine composition formulated with a novel TLR7-dependent adjuvant induces high and broad protection against Staphylococcus aureus 237
Auto-assembling detoxified staphylococcus aureus alpha-hemolysin mimicking the wild-type cytolytic toxin 232
Synergistic protective activity of tumor-specific epitopes engineered in bacterial outer membrane vesicles 215
Bacterial outer membrane vesicles engineered with lipidated antigens as a platform for Staphylococcus aureus vaccine 212
The human pathogen Streptococcus pyogenes releases lipoproteins as lipoprotein-rich membrane vesicles 211
Streptococcus agalactiae capsule polymer length and attachment is determined by the proteins CpsABCD 210
Analysis of two-component systems in group B streptococcus shows that RgfAC and the novel FspSR modulate virulence and bacterial fitness 209
One dose of staphylococcus aureus 4C-staph vaccine formulated with a novel TLR7-dependent adjuvant rapidly protects mice through antibodies, effector CD4+ T Cells, and IL-17A 206
Whole-genome epidemiology, characterisation, and phylogenetic reconstruction of Staphylococcus aureus strains in a paediatric hospital 204
Large scale validation of an efficient CRISPR/Cas-based multi gene editing protocol in Escherichia coli 198
Identification of the central tolerance checkpoint for autoreactive proteinase 3+ B cells in human bone marrow 196
Negatively charged AuNP modified with monoclonal antibody against novel tumor antigen FAT1 for tumor targeting 196
CD81 extracellular domain 3D structure: Insight into the tetraspanin superfamily structural motifs 193
Protective effect of Group B Streptococcus type-III polysaccharide conjugates against maternal colonization, ascending infection and neonatal transmission in rodent models 193
Vaccinology: The art of putting together the right ingredients 191
Understanding the Molecular Determinants Driving the Immunological Specificity of the Protective Pilus 2a Backbone Protein of Group B Streptococcus 182
Proteome-minimized outer membrane vesicles from Escherichia coli as a generalized vaccine platform 181
Angiopoietin-like 7, a novel pro-angiogenetic factor over-expressed in cancer 178
Targeted amino acid substitutions impair streptolysin O toxicity and group a Streptococcus virulence 175
Genomic analysis reveals the molecular basis for capsule loss in the group B Streptococcus population 175
New insights into the role of the glutamic acid of the E-box motif in group B Streptococcus pilus 2a assembly. 175
FAT1: A potential target for monoclonal antibody therapy in colon cancer 169
A structure-based approach to rationally design a chimeric protein for an effective vaccine against Group B Streptococcus infections. 168
Approach to discover T and B cell antigens of intracellular pathogens applied to the design of Chlamydia trachomatis vaccines. 168
Sequence and analysis of the genetic locus responsible for surfactin synthesis in Bacillus subtilis 167
Multiple Stepwise Gene Knockout Using CRISPR/Cas9 in Escherichia coli 164
A rapid and versatile site-directed method of mutagenesis for double-stranded plasmid DNA 162
Structural Basis for Group B Streptococcus Pilus 1 Sortases C Regulation and Specificity 162
Structural vaccinology starts to deliver 162
Cloning and nucleotide sequence of the isoamylase gene from a strain of Pseudomonas sp 156
Recombinant outer membrane vesicles carrying Chlamydia muridarum HtrA induce antibodies that neutralize chlamydial infection in vitro 155
The Protective Value of Maternal Group B Streptococcus Antibodies: Quantitative and Functional Analysis of Naturally Acquired Responses to Capsular Polysaccharides and Pilus Proteins in European Maternal Sera 155
ERMP1, a novel potential oncogene involved in UPR and oxidative stress defense, is highly expressed in human cancer 153
MF59- and Al(OH)3-adjuvanted Staphylococcus aureus (4C-Staph) vaccines induce sustained protective humoral and cellular immune responses, with a critical role for effector CD4 T cells at low antibody titers 153
Sequence type 1 group B Streptococcus, an emerging cause of invasive disease in adults, evolves by small genetic changes 152
Antibacterial vaccine design using genomics and proteomics 151
SpyAD, a moonlighting protein of group A Streptococcus contributing to bacterial division and host cell adhesion 150
Identification of new potential vaccine candidates against Chlamydia pneumoniae by multiple screenings 148
Inferring reasons for the failure of Staphylococcus aureus vaccines in clinical trials. 148
Rational antibacterial vaccine design through genomic technologies 146
Commensal Bifidobacterium Strains Enhance the Efficacy of Neo-Epitope Based Cancer Vaccines 145
Outer membrane vesicles from the gut microbiome contribute to tumor immunity by eliciting cross-reactive T cells 144
Engineering outer membrane vesicles 144
A novel polyclonal antibody library for expression profiling of poorly characterized, membrane and secreted human proteins. 144
Antibody-mediated immunity induced by engineered Escherichia coli Outer Membrane Vesicles (OMVs) carrying heterologous antigens in their lumen 142
Three-dimensional human skin models to understand Staphylococcus aureus skin colonization and infection 136
Structure and protective efficacy of the Staphylococcus aureus autocleaving protease EpiP 135
Crystal structures of the components of the Staphylococcus aureus leukotoxin ED 133
Functional activity of maternal and cord antibodies elicited by an investigational group B Streptococcus trivalent glycoconjugate vaccine in pregnant women. 132
The impact of genomics in vaccine discovery: achievements and lessons 130
Autoreactive Plasmablasts After B Cell Depletion With Rituximab and Relapses in Antineutrophil Cytoplasmic Antibody-Associated Vasculitis 127
Four-component Staphylococcus aureus vaccine 4C-staph enhances fcγ receptor expression in neutrophils and monocytes and mitigates S. aureus infection in neutropenic mice 126
Immunogenicity and Pre-Clinical Efficacy of an OMV-Based SARS-CoV-2 Vaccine 125
Anti-Tumor Efficacy of In Situ Vaccination Using Bacterial Outer Membrane Vesicles 123
Sortase A substrate specificity in GBS pilus 2a cell wall anchoring. 122
Streptococcus pyogenes SpyCEP influences host-pathogen interactions during infection in a murine air pouch model 121
Staphylococcus aureus FhuD2 is involved in the early phase of staphylococcal dissemination and generates protective immunity in mice. 118
Identification of a Universal Group B Streptococcus Vaccine by Multiple Genome Screen. 114
A Bacillus subtilis large ORF coding for a polypeptide highly similar to polyketide synthases. 113
Gene expression profile in Neisseria meningitidis and Neisseria lactamica upon host-cell contact: from basic research to vaccine development 110
Structural vaccinology starts to deliver 108
Outer Membrane Vesicles From The Gut Microbiome Contribute to Tumor Immunity by Eliciting Cross-Reactive T Cells 108
Cumulative stabilizing effects of hydrophobic interactions on the surface of the neutral protease from Bacillus subtilis 107
The complete genome sequence of the gram-positive bacterium Bacillus subtilis 107
Multi High-Throughput Approach for Highly Selective Identification of Vaccine Candidates: the Group A Streptococcus Case. 107
Immobilized metal-ion affinity chromatography of human growth hormone 104
Recombinant and truncated tetanus neurotoxin light chain: Cloning, expression, purification, and proteolytic activity 104
Identification of vaccine candidates against serogroup B meningococcus genome sequencing. 103
Surface Interactome in Streptococcus pyogenes. 102
Structure and protective efficacy of the Staphylococcus aureus autocleaving protease EpiP 100
TCTN2: A novel tumor marker with oncogenic properties 98
R-factor mediated suppression of the galacto-sensitive phenotype of E.coli K12 galE mutants. 97
Structural and functional characterization of the Staphylococcus aureus virulence factor and vaccine candidate FhuD2 97
Phagocyte subsets and lymphocyte clonal deletion behind ineffective immune response to Staphylococcus aureus 96
Mining the bacterial unknown proteome: Identification and characterization of a novel family of highly conserved protective antigens in Staphylococcus aureus 88
Characterization of the locus encoding the [Ni-Fe] sulfhydrogenase from the archaeon Pyrococcus furiosus: evidence for a relationship to bacterial sulfite reductases. 88
Circulating autoreactive proteinase 3+ B cells and tolerance checkpoints in ANCA-associated vasculitis 88
Meta-analysis of immune-related adverse events in phase 3 clinical trials assessing immune checkpoint inhibitors for lung cancer 87
tructure analysis and site-directed mutagenesis of defined key residues and motives for pilus-related sortase C1 in group B Streptococcus. 86
Structure, dynamics and immunogenicity of a catalytically inactive CXC chemokine-degrading protease SpyCEP from Streptococcus pyogenes 86
Model building of a thermolysin-like protease by mutagenesis. 85
Purification of recombinant human growth hormone by isoelectric focusing in a multicompartment electrolyzer with Immobiline membranes. 81
Identification of novel iron-activated and -repressed fur-dependent genes by transcriptome analysis of Neisseria meningitidis group B 77
Efficient conversion of 5-substituted hydantoins to D-amino acids using recombinant E. coli strains 75
Grafting of a calcium binding loop of thermolysin to B. subtilis neutral protease. 64
Rheumatic immune-and nonimmune-related adverse events in phase 3 clinical trials assessing PD-(L)1 checkpoint inhibitors for lung cancer: A systematic review and meta-analysis 63
Investigation on antigen-specific T-cell responses induced by outer membrane vesicles from Escherichia coli Δ60 strain 48
Totale 13.455
Salva come PNG Salva come JPEG
Categoria #
all - tutte 53.948
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 53.948
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022758 0 0 0 0 28 42 34 219 59 96 118 162
2022/20231.018 150 154 23 134 89 156 10 80 108 8 57 49
2023/2024339 24 34 21 16 30 46 46 14 4 16 33 55
2024/20251.699 10 6 74 408 60 246 30 90 173 298 105 199
2025/20264.051 246 126 563 965 287 245 683 103 342 275 131 85
2026/20271.518 91 204 388 690 145 0 0 0 0 0 0 0
Totale 13.455